Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts

Haematologica

Volumn 89, Issue 4, 2004, Pages 391-402

  Bruserud, Øystein ^a   Ryningen, Anita ^a   Wergeland, Line ^a   Glenjen, Nils Idar ^a   Gjertsen, Bjørn Tore ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myelogenous leukemia; Apoptosis; Interleukin 8; Osteoblasts

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 8;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLAST CELL; CANCER PATIENT; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN CAL 72; CELL STRAIN SJSA 1; CLINICAL ARTICLE; CLONOGENESIS; CYTOKINE RELEASE; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MALE; OSTEOBLAST; SARCOMA CELL; STEM CELL;

APOPTOSIS; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; HUMANS; INTERLEUKIN-8; LEUKEMIA, MYELOCYTIC, ACUTE; NEOVASCULARIZATION, PATHOLOGIC; OSTEOBLASTS; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

EID: 2942711332     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051-62.
2. Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, et al. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derived from the MRC AML 10 trial. Br J Haematol 1999;107:69-79.
3. Mrozek K, Heinonen K, de la Chapelle A, Bloomfield CD. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997;24:17-31.
4. Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12. Blood 2001;98:1752-9.
5. Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, et al. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and internal tandem duplication of FLT3: a Cancer and Leukemia Group B study. Cancer Res 2001;61:7233-9.
6. Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, et al. Analysis of Flt3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002;99:4326-35.
7. Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95:2637-44.
8. Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M, Giles F, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999;94:3717-21.
9. Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, et al. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 2002;95:1923-30.
10. Lai R, Estey E, Shen Y, Despa S, Kantarjian H, Beran M, et al. Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome. Cancer 2002;94:14-7.
11. Garrido SM, Appelbaum FR, Willman CL, Banker DE. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human marrow stromal cell line (HS-5). Exp Hematol 2001;29:448-57.
12. Dührsen U, Knieling G, Beecken W, Neumann S, Hossfeld DK. Chimaeric cultures of human marrow stroma and murine leukaemia cells: evidence for abnormalities in the haematopoietic microenvironment in myeloid malignancies and other infiltrating marrow disorders. Br J Haematol 1995;90:502-11.
13. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;289:1501-4.
14. Rochet N, Leroy P, Far DF, Ollier L, Loubat A, Rossi B. CAL72: a human osteosarcoma cell line with unique effects on hematopoietic cells. Eur J Haematol 2003;70:43-52.
15. Nelissen JM, Torensma R, Pluyter M, Adema GJ, Raymakers RA, van Kooyk Y, et al. Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS. Exp Hematol 2000;28:422-32.
16. Taichman RS, Reilly MJ, Matthews LS. Human osteoblast-like cells and osteosarcoma cell lines synthesize macrophage inhibitory protein 1α in response to interleukin 1β and tumour necrosis factor a stimulation in vitro. Br J Haematol 2000;108:275-83.
17. Taichman RS, Emerson SG. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 1998;16:7-15.
18. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. Leukemia 1995;9:1783-6.
19. Bruserud Ø, Huang TS, Glenjen N, Gjertsen BT, Foss B. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemic blasts. Haematologica 2002;87:584-95.
20. Bruserud Ø, Gjertsen BT, Brustugun OT, Bassøe CF, Nesthus I, Akselsen PE, et al. Effect of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 1995;9:1910-20.
21. Bruserud Ø. Effects of dipyridamole, theophyllamine and verapamil on spontaneous proliferation of myelogenous leukemia cells. Acta Oncol 1992;31:53-8.
22. Rochet N, Dubousset J, Mazeau C, Zanghellini E, Farges MF, de Novion HS, et al. Establishment, characterization and partial cytokine expression profile of a new human osteosarcoma cell line (CAL72). Int J Cancer 1999;82:282-5.
23. Bruserud Ø, Glenjen NI, Ryningen A, Ulvestad E. In vitro culture of human acute myelogenous leukemia (ALL) cells in serum-free media: a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines. Leuk Res 2003;27:455-64.
24. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early cells using fluorescein labeled annexin V. J Immunol Methods 1995;184:39-51.
25. Bruserud Ø, Hovland R, Wergeland L, Huang TS, Gjertsen BT. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of the effects of Flt3-ligand in AML cell populations with and without Flt3 abnormalities. Haematologica 2003;88:416-28.
26. Steensma DP, Timm M, Witzig TE. Flow cytometric methods for detection and quantification of apoptosis. Methods Mol Med 2003;85:323-32.
27. Bruserud Ø, Gjertsen BT, Foss B, Huang T-s. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells - the present use in experimental studies and the possible importance for future therapeutic strategies. Stem Cells 2001;19:1-11.
28. Bruserud Ø, Gjertsen BT, von Volkman HL In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res 2000;9:923-32.
29. Bruserud O, Frostad S, Foss B. In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media. J Hematother 1999;8:63-73.
30. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haematopoiesis. Nature 1988;3332:276-8.
31. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by upregulation of anti-apoptotic proteins. Leukemia 2002;16:1713-24.
32. Bradstock KF, Gottlieb DJ. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma 1995;18:1-16.
33. Bendall LJ, Daniel A, Kortlepel K, Gottlieb DJ. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol 1994;22:1252-60.
34. Burger A, Spoo A, Dwenger A, Burger M, Behringer D. CXCR4 chemokine receptor (CD184) and α4β1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukemia cells beneath marrow stromal cells (pseudoemperipolesis). Br J Haematol 2003;122:579-89.
35. Glenjen NI, Hovland R, Wergeland L, Wendelbo Ø, Ernst P, Bruserud Ø. The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status. Eur J Haematol 2003;71:163-73.
36. Vinante F, Rigo A, Vincenzi C, Ricetti MM, Marrocchella R, Chilosi M, et al. IL8 mRNA expression and IL8 production by acute myeloid leukemia cells. Leukemia 1993;7:1552-6.
37. De Bont ES, Vellenga E, Molema G, van Wering E, de Leij LF, Kamps WA. A possible role for spontaneous interleukin-8 production by acute myeloid leukemic cells in angiogenesis related processes: work in progress. Med Pediatr Oncol 2001;37:511-7.